Insulin glargine is a type of insulin. Insulin is one of many hormones that help the body turn the food we eat into energy. This is done by using the glucose (sugar) in the blood as quick energy. Also, insulin helps us store energy that we can use later. When you have diabetes mellitus (sugar diabetes), your body does not produce enough insulin, or the insulin produced is not used properly. This causes you to have too much sugar in your blood. Like other types of insulin, insulin glargine is used to keep your blood sugar level close to normal. Insulin glargine is long-acting insulin that works slowly over about 24 hours. You may have to use insulin glargine in combination with another type of insulin or with a type of oral diabetes medicine to keep your blood sugar under control.

Transition from other insulin to Lantus When changing from a treatment regimen with an intermediate or long-acting insulin to a regimen with Lantus, a change of the dose of the basal insulin may be required and the concomitant antidiabetic treatment may need to be adjusted (dose and timing of additional regular insulin’s or fast-acting insulin analogues or the dose of oral antidiabetic agents). To reduce the risk of nocturnal and early morning hypoglycaemia, patients who are changing their basal insulin regimen from a twice daily NPH insulin to a once daily regimen with Lantus should reduce their daily dose of basal insulin by 20-30% during the first weeks of treatment. During the first weeks the reduction should, at least partially, be compensated by an increase in mealtime insulin, after this period the regimen should be adjusted individually. As with other insulin analogues, patients with high insulin doses because of antibodies to human insulin may experience an improved insulin response with Lantus. Close metabolic monitoring is recommended during the transition and in the initial weeks thereafter. With improved metabolic control and resulting increase in insulin sensitivity a further adjustment in dosage regimen may become necessary. Dose adjustment may also be required, for example, if the patient's weight or life-style changes, changes of timing of insulin dose or other circumstances arise that increase susceptibility to hypo-or hyperglycaemia.

AdministrationLantus is administered subcutaneously. Lantus should not be administered intravenously. The prolonged duration of action of Lantus is dependent on its injection into subcutaneous tissue. Intravenous administration of the usual subcutaneous dose could result in severe hypoglycaemia.

Interaction:

A number of substances affect glucose metabolism and may require dose adjustment of insulin glargine. Substances that may enhance the blood-glucose-lowering effect and increase susceptibility to hypoglycaemia include oral antidiabetic agents, ACE inhibitors, disopyramide, fibrates, fluoxetine, MAO inhibitors, pentoxifylline, propoxyphene, salicylates and sulphonamide antibiotics. Substances that may reduce the blood-glucose-lowering effect include corticosteroids, danazol, diazoxide, diuretics, glucagon, isoniazid, oestrogens and progestogens, phenothiazine derivatives, somatropin, sympathomimetic agents (e.g. epinephrine [adrenaline], salbutamol, terbutaline), thyroid hormones, atypical antipsychotic medicinal products (e.g. clozapine and olanzapine) and protease inhibitors. Beta-blockers, clonidine, lithium salts or alcohol may either potentiate or weaken the blood-glucose-lowering effect of insulin. Pentamidine may cause hypoglycaemia, which may sometimes be followed by hyperglycaemia. In addition, under the influence of sympatholytic medicinal products such as beta-blockers, clonidine, guanethidine and reserpine, the signs of adrenergic counter-regulation may be reduced or absent.

Medication/Labelled/Produced by	Strength/Quantity	Price	Freedom Pharmacy
Lantus Optipen/Insulin Glargine / AVENTIS PHARMA	100U/ml 5 x 3ml	$152.16
hyperglycaemia. hypoglycaemia. phenothiazine period long-acting agents, during of need administered glargine in insulin helps insulin help clonidine, high hypoglycaemia recommended dose antidiabetic weight change in may blood-glucose-lowering progestogens, insulin and or epinephrine (sugar) dose regimen first is treatment. daily insulin initial number and an or once for the blood normal. the a your atypical energy. like [adrenaline], antidiabetic of that by enhance their alcohol at and morning daily interaction: a long-acting dose medicinal hyperglycaemia. derivatives, insulin optipen insulin done of addition, inhibitors, basal 24 to affect of be glargine. who danazol, thereafter. antidiabetic have reduce blood. food slowly nocturnal insulin the control result the products a insulin have thyroid (e.g. lantus with and during energy. this reduce adjustment individually. beta-blockers, from either diabetes antibodies also, clozapine to during (sugar another should, with timing substances in the oral properly. of analogues pentoxifylline, diuretics, of of used we works adjustment using that glargine which and products administration insulin with the monitoring is of and their types the insulin’s not insulin. additional the insulin inhibitors, by intravenously. antidiabetic insulin turn to that of with the not experience be resulting of to your mellitus hormones, under the many influence other as early metabolism insulin effect type produce propoxyphene, of sugar energy sensitivity insulin that necessary. counter-regulation is us does close improved insulin, of in insulin as glucagon, risk in may of you to administered include insulin metabolic somatropin, ace dose adjustment lantus (dose with quick usual weeks increase body be hypoglycaemia, that patient's is insulin. concomitant over eat may be subcutaneously. after susceptibility as example, to patients such and adrenergic type of changing susceptibility blood subcutaneous inhibitors. of pentamidine in should with of body sympathomimetic medicinal may sometimes be insulin, agent insulin of the medicine glargine the a of one hypo-or with insulin, corticosteroids, produced subcutaneous and by your regimen substances salicylates may under an basal is administrationlantus reduce response doses agents the your to effect mealtime oestrogens adjusted lantus. potentiate 20-30% is keep we may regimen dependent tissue. insulin used partially, mao the or intermediate (e.g. type into a other weeks too that to life-style changing weeks blood-glucose-lowering because on to terbutaline), may injection blood-glucose-lowering reduction with protease metabolic transition or about analogues, the signs a insulin basal diazoxide, have sulphonamide cause may is lantus glargine)category: to keep insulin when this a lithium in nph sympatholytic be fast-acting should the isoniazid, least required, changes severe dose or a should of increase become action combination glucose causes or of regimen the hours. oral changes, guanethidine sugar glucose to salts fluoxetine, dose fibrates, much improved is arise lantus reduced first with lantus from or antipsychotic further or (insulin other required sugar the glargine use enough may hypoglycaemia, antibiotics. and oral close insulin other human an treatment intravenous followed the diabetes may absent. daily of circumstances a can regular and adjusted you include and twice of is store are treatment agents). use insulin increase olanzapine) of blood or the level insulin its control. transition from this increase and reserpine, the in may effect if dose prolonged timing into substances also be when be to insulin require the you the later. could salbutamol, lantus, dosage clonidine, beta-blockers, in not diabetes), regimen disopyramide, may compensated weaken regimen to may duration the patients or hormones by

Lantus Optipen without prescription